Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · IEX Real-Time Price · USD
1.050
-0.120 (-10.26%)
At close: Jul 26, 2024, 4:00 PM
1.070
+0.020 (1.90%)
After-hours: Jul 26, 2024, 6:45 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $4.44 million as of July 26, 2024. Its market cap has decreased by -52.20% in one year.
Market Cap
4.44M
Enterprise Value
-580.13K
1-Year Change
-52.20%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.30M to $4.44M, a decrease of -83.10%. That is a compound annual growth rate of -25.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 5.00M | 117.39% |
| Dec 29, 2023 | 2.30M | -60.34% |
| Dec 30, 2022 | 5.80M | -89.66% |
| Dec 31, 2021 | 56.10M | 131.82% |
| Dec 31, 2020 | 24.20M | -2.81% |
| Dec 31, 2019 | 24.90M | -25.89% |
| Dec 31, 2018 | 33.60M | 27.76% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biofrontera | 5.34M |
| Ainos | 5.33M |
| Sharps Technology | 5.33M |
| XORTX Therapeutics | 5.28M |
| Leafly Holdings | 5.28M |
| BioCardia | 5.21M |
| TransCode Therapeutics | 5.18M |
| Clearmind Medicine | 5.17M |